Dr. Kaylyn Sinicrope, MD
Claim this profileNorton Healthcare
Studies Glioblastoma
Studies Brain Tumor
6 reported clinical trials
9 drugs studied
Area of expertise
1Glioblastoma
IDH negative
IDH positive
MET positive
2Brain Tumor
H3 K27M positive
MET positive
MET negative
Affiliated Hospitals
Clinical Trials Kaylyn Sinicrope, MD is currently running
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
Oral OKN-007
for Brain Tumor
This is a phase 1 open-label, multicenter study to investigate tolerability, safety and PK properties of oral OKN-007 in patients with recurrent high-grade glioma.
Recruiting1 award Phase 1
More about Kaylyn Sinicrope, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kaylyn Sinicrope, MD has experience with
- OKN-007
- ONC201
- Optune®
- SurVaxM
- Temozolomide
- GSK2256098
Breakdown of trials Kaylyn Sinicrope, MD has run
Glioblastoma
Brain Tumor
Mesial Temporal Sclerosis
Oligodendroglioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kaylyn Sinicrope, MD specialize in?
Kaylyn Sinicrope, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are IDH positive.
Is Kaylyn Sinicrope, MD currently recruiting for clinical trials?
Yes, Kaylyn Sinicrope, MD is currently recruiting for 3 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Kaylyn Sinicrope, MD has studied deeply?
Yes, Kaylyn Sinicrope, MD has studied treatments such as OKN-007, ONC201, Optune®.
What is the best way to schedule an appointment with Kaylyn Sinicrope, MD?
Apply for one of the trials that Kaylyn Sinicrope, MD is conducting.
What is the office address of Kaylyn Sinicrope, MD?
The office of Kaylyn Sinicrope, MD is located at: Norton Healthcare, Louisville, Kentucky 40241 United States. This is the address for their practice at the Norton Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.